2022 update on prostate cancer epidemiology and risk factors—a systematic review

O Bergengren, KR Pekala, K Matsoukas, J Fainberg… - European urology, 2023 - Elsevier
Abstract Context Prostate cancer (PCa) is one of the most common cancers worldwide.
Understanding the epidemiology and risk factors of the disease is paramount to improve …

Polygenic scores in cancer

X Yang, S Kar, AC Antoniou, PDP Pharoah - Nature reviews Cancer, 2023 - nature.com
Since the publication of the first genome-wide association study for cancer in 2007,
thousands of common alleles that are associated with the risk of cancer have been …

[HTML][HTML] Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study

Y Long, L Tang, Y Zhou, S Zhao, H Zhu - BMC medicine, 2023 - Springer
Background Evidence from observational studies and clinical trials suggests that the gut
microbiota is associated with cancer. However, the causal association between gut …

Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

C Fernandez-Rozadilla, M Timofeeva, Z Chen, P Law… - Nature …, 2023 - nature.com
Colorectal cancer (CRC) is a leading cause of mortality worldwide. We conducted a genome-
wide association study meta-analysis of 100,204 CRC cases and 154,587 controls of …

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

A Wang, J Shen, AA Rodriguez, EJ Saunders, F Chen… - Nature …, 2023 - nature.com
The transferability and clinical value of genetic risk scores (GRSs) across populations
remain limited due to an imbalance in genetic studies across ancestrally diverse …

[HTML][HTML] Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases

S Yuan, L Wang, H Zhang, F Xu, X Zhou, L Yu, J Sun… - …, 2023 - thelancet.com
Background To explore the associations of genetically proxied TYK2 inhibition with a wide
range of disease outcomes and biomarkers to identify therapeutic repurposing opportunities …

Gut microbiota and risk of five common cancers: A univariable and multivariable Mendelian randomization study

Z Wei, B Yang, T Tang, Z Xiao, F Ye, X Li… - Cancer …, 2023 - Wiley Online Library
Background Previous studies have linked gut microbiota with cancer etiology, but the
associations for specific gut microbiota are causal or owing to bias remain to be elucidated …

[HTML][HTML] Recurrent repeat expansions in human cancer genomes

GS Erwin, G Gürsoy, R Al-Abri, A Suriyaprakash… - Nature, 2023 - nature.com
Expansion of a single repetitive DNA sequence, termed a tandem repeat (TR), is known to
cause more than 50 diseases,. However, repeat expansions are often not explored beyond …

Genetic risk prediction for prostate cancer: implications for early detection and prevention

TM Seibert, IP Garraway, A Plym, BA Mahal, V Giri… - European urology, 2023 - Elsevier
Abstract Context Prostate cancer (PCa) is a leading cause of death and partially heritable.
Genetic risk prediction might be useful for strategies to reduce PCa mortality through early …

Evidence of novel susceptibility variants for prostate cancer and a multiancestry polygenic risk score associated with aggressive disease in men of African ancestry

F Chen, RK Madduri, AA Rodriguez, BF Darst, A Chou… - European urology, 2023 - Elsevier
Background Genetic factors play an important role in prostate cancer (PCa) susceptibility.
Objective To discover common genetic variants contributing to the risk of PCa in men of …